Preview Mode Links will not work in preview mode

Precisione: The Healthcast


Feb 7, 2020

Dr. Crystal Icenhour, PhD
Crystal R Icenhour, PhD, is one of the rising stars of American biotechnology. After more than 25 years in medical research and biotech, she was named founding CEO of Aperiomics, a company that harnesses the power of next-generation DNA sequencing to identify any known pathogen (bacteria, virus, fungi or parasite). Aperiomics is the only company of its kind and scope in the world. Throughout Dr. Icenhour’s career, she has demonstrated strong leadership in business and science and has dedicated herself to “bridging the translational gap between these two worlds.”

What you will learn from this episode:
1) How to use DNA sequencing to find out what is making you sick
2) Is candida and Lyme a real problem?
3) What the difference is between culturing bacteria and identifying them using the technology of Aperiomics
4) How to use stool microbiome testing to figure out what is causing your chronic symptoms
5) Where the future of pathogen identification is going

How to learn more about our guest:

Name: Dr. Crystal Icenhour, PhD.
Company:Aperiomics
Job Title/Role: CEO and Co-Founder
Address: 45925 Horseshoe Dr. (Suite 170), Sterling, Virginia 20166
Email address: Aperiomics@Waxmanstrategies.com
PR Contact Phone number: +1 (202) 802-0504
Twitter handle: @Aperiomics
Website:https://aperiomics.com/

About Aperiomics:

The only company of its kind and scope in the world combining advanced DNA testing, the power of big data and decades of infectious disease expertise, Aperiomics is revolutionizing the way that medical professionals around the world identify infections. Supported by the National Science Foundation, Aperiomics identifies every known bacteria, virus, fungus, and parasite through deep shotgun metagenomic sequencing, using its proprietary, world-renowned database containing over 37,000 microorganisms. Helping doctors and their patients identify the causes of infections that other tests cannot identify, Aperiomics streamlines the path to a positive clinical outcome. Responsible for solving more than 1,000 medical mysteries, patients and their physicians often contact Aperiomics after suffering with medical conditions for years and hearing about Aperiomics’ life-changing success stories. Aperiomics was named Life Science Innovator of the Year in 2016 and International Start Up of the Year in 2018.

Please enjoy, share, rate and review our podcast and help us bring the message about precision health care to the world!

Dr. Crystal Icenhour, PhD, is one of the rising stars of American biotechnology. After more than 25 years in medical research and biotech, she was named founding CEO of Aperiomics, a company that harnesses the power of next-generation DNA sequencing to identify any known pathogen (bacteria, virus, fungi or parasite). Aperiomics is the only company of its kind and scope in the world. Throughout Dr. Icenhour’s career, she has demonstrated strong leadership in business and science and has dedicated herself to “bridging the translational gap between these two worlds.”

What you will learn from this episode:
1) How to use DNA sequencing to find out what is making you sick
2) Is candida and Lyme a real problem?
3) What the difference is between culturing bacteria and identifying them using the technology of Aperiomics
4) How to use stool microbiome testing to figure out what is causing your chronic symptoms
5) Where the future of pathogen identification is going

How to learn more about our guest:

Name: Dr. Crystal Icenhour, PhD.
Company:Aperiomics
Job Title/Role: CEO and Co-Founder
Address: 45925 Horseshoe Dr. (Suite 170), Sterling, Virginia 20166
Email address: Aperiomics@Waxmanstrategies.com
PR Contact Phone number: +1 (202) 802-0504
Twitter handle: @Aperiomics
Website:https://aperiomics.com/

About Aperiomics:

The only company of its kind and scope in the world combining advanced DNA testing, the power of big data and decades of infectious disease expertise, Aperiomics is revolutionizing the way that medical professionals around the world identify infections. Supported by the National Science Foundation, Aperiomics identifies every known bacteria, virus, fungus, and parasite through deep shotgun metagenomic sequencing, using its proprietary, world-renowned database containing over 37,000 microorganisms. Helping doctors and their patients identify the causes of infections that other tests cannot identify, Aperiomics streamlines the path to a positive clinical outcome. Responsible for solving more than 1,000 medical mysteries, patients and their physicians often contact Aperiomics after suffering with medical conditions for years and hearing about Aperiomics’ life-changing success stories. Aperiomics was named Life Science Innovator of the Year in 2016 and International Start Up of the Year in 2018.

Please enjoy, share, rate and review our podcast and help us bring the message about precision health care to the world!